AFM
BIOR

Anson Funds Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Anson Funds Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,713
Closed -$2.38M – 196
2023
Q2 		$2.38M Buy
+61,713
New +$2.18M 0.39% 47

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Anson Funds Management's BIOR Position: Q3 2023 in Review

Anson Funds Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2023, closing a stake of 61,713 shares — an estimated $2.38M sold.

Anson Funds Management first reported a position in BIOR in Q2 2023 and held it in 1 quarter. The position peaked at $2.38M in Q2 2023. 24 funds tracked by Wall St. Rank hold BIOR as of Q3 2023.

  • Anson Funds Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Anson Funds Management sold 61,713 Biora Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.38M.
  • Anson Funds Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Anson Funds Management's Biora Therapeutics, Inc. Common Stock position peaked at $2.38M in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Anson Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.